Literature DB >> 22172388

Influence of cations on the complexation yield of DOTATATE with yttrium and lutetium: a perspective study for enhancing the 90Y and 177Lu labeling conditions.

Mattia Asti1, Matteo Tegoni, Daniela Farioli, Michele Iori, Claudio Guidotti, Cathy S Cutler, Pat Mayer, Annibale Versari, Diana Salvo.   

Abstract

The DOTA macrocyclic ligand can form stable complexes with many cations besides yttrium and lutetium. For this reason, the presence of competing cationic metals in yttrium-90 and lutetium-177 chloride solutions can dramatically influence the radiolabeling yield. The aim of this study was to evaluate the coordination yield of yttrium- and lutetium-DOTATATE complexes when the reaction is performed in the presence of varying amounts of competing cationic impurities. In the first set of experiments, the preparation of the samples was performed by using natural yttrium and lutetium (20.4 nmol). The molar ratio between DOTATATE and these metals was 1 to 1. Metal competitors (Pb(2+), Zn(2+), Cu(2+), Fe(3+), Al(3+), Ni(2+), Co(2+), Cr(3+)) were added separately to obtain samples with varying molar ratio with respect to yttrium or lutetium (0.1, 0.5, 1, 2 and 10). The final solutions were analyzed through ultra high-performance liquid chromatography with an UV detector. In the second set of experiments, an amount of (90)Y or (177)Lu chloride (6 MBq corresponding to 3.3 and 45 pmol, respectively) was added to the samples, and a radio-thin layer chromatography analysis was carried out. The coordination of Y(3+) and Lu(3+) was dramatically influenced by low levels of Zn(2+), Cu(2+) and Co(2+). Pb(2+) and Ni(2+) were also shown to be strong competitors at higher concentrations. Fe(3+) was expected to be a strong competitor, but the effect on the incorporation was only partly dependent on its concentration. Al(3+) and Cr(3+) did not compete with Y(3+) and Lu(3+) in the formation of DOTATATE complexes.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22172388     DOI: 10.1016/j.nucmedbio.2011.10.015

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  6 in total

1.  Novel Preparation Methods of (52)Mn for ImmunoPET Imaging.

Authors:  Stephen A Graves; Reinier Hernandez; Jesper Fonslet; Christopher G England; Hector F Valdovinos; Paul A Ellison; Todd E Barnhart; Dennis R Elema; Charles P Theuer; Weibo Cai; Robert J Nickles; Gregory W Severin
Journal:  Bioconjug Chem       Date:  2015-09-10       Impact factor: 4.774

2.  High-throughput radio-TLC analysis.

Authors:  Jia Wang; Alejandra Rios; Ksenia Lisova; Roger Slavik; Arion F Chatziioannou; R Michael van Dam
Journal:  Nucl Med Biol       Date:  2019-12-17       Impact factor: 2.408

3.  Production of Mass-Separated Erbium-169 Towards the First Preclinical in vitro Investigations.

Authors:  Zeynep Talip; Francesca Borgna; Cristina Müller; Jiri Ulrich; Charlotte Duchemin; Joao P Ramos; Thierry Stora; Ulli Köster; Youcef Nedjadi; Vadim Gadelshin; Valentin N Fedosseev; Frederic Juget; Claude Bailat; Adelheid Fankhauser; Shane G Wilkins; Laura Lambert; Bruce Marsh; Dmitry Fedorov; Eric Chevallay; Pascal Fernier; Roger Schibli; Nicholas P van der Meulen
Journal:  Front Med (Lausanne)       Date:  2021-04-22

4.  Feasibility study and direct extraction of endogenous free metallic cations combining hemodialysis and chelating polymer.

Authors:  Marco Natuzzi; Coralie Grange; Thomas Gréa; Thomas Brichart; Axel Aigle; Denise Bechet; Benoit Hautefeuille; Eloise Thomas; Jean-Yves Ayoub; Jeanne-Marie Bonnet; Vanessa Louzier; Bernard Allaouchiche; Aymeric Couturier; Alexandra Montembault; Paula Nunes de Oliveira; Laurent David; François Lux; Olivier Tillement
Journal:  Sci Rep       Date:  2021-10-07       Impact factor: 4.379

5.  Production and characterization of no-carrier-added 161Tb as an alternative to the clinically-applied 177Lu for radionuclide therapy.

Authors:  Nadezda Gracheva; Cristina Müller; Zeynep Talip; Stephan Heinitz; Ulli Köster; Jan Rijn Zeevaart; Alexander Vögele; Roger Schibli; Nicholas P van der Meulen
Journal:  EJNMMI Radiopharm Chem       Date:  2019-07-10

6.  C-terminal-modified LY2510924: a versatile scaffold for targeting C-X-C chemokine receptor type 4.

Authors:  Kentaro Suzuki; Takashi Ui; Akio Nagano; Akihiro Hino; Yasushi Arano
Journal:  Sci Rep       Date:  2019-10-25       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.